TreeWAS – Variant ID: rs2798641

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	0.371	0.629	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.367	0.633	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.367	0.633	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.365	0.635	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.362	0.638	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.342	0.658	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.338	0.662	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.334	0.666	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.304	0.695	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.299	0.701	0.000
T45.0 Antiallergic and antiemetic drugs	0.297	0.703	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.293	0.707	0.000
T45.2 Vitamins, not elsewhere classified	0.292	0.708	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.288	0.712	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.281	0.719	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.278	0.722	0.000
T42.0 Hydantoin derivatives	0.278	0.722	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.278	0.722	0.000
T39.0 Salicylates	0.276	0.724	0.000
T42.1 Iminostilbenes	0.270	0.730	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.269	0.730	0.000
T39.1 4-Aminophenol derivatives	0.269	0.731	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.266	0.734	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.266	0.734	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.266	0.734	0.000
T45.5 Anticoagulants	0.265	0.735	0.000
T50.8 Diagnostic agents	0.263	0.737	0.000
T50.7 Analeptics and opioid receptor antagonists	0.263	0.737	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.263	0.737	0.000
T50.5 Appetite depressants	0.263	0.737	0.000
T50.4 Drugs affecting uric acid metabolism	0.263	0.737	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.263	0.737	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.263	0.737	0.000
T50.1 Loop [high-ceiling] diuretics	0.263	0.737	0.000
T50.0 Mineralocorticoids and their antagonists	0.263	0.737	0.000
T39.4 Antirheumatics, not elsewhere classified	0.263	0.737	0.000
T39.2 Pyrazolone derivatives	0.263	0.737	0.000
T46.1 Calcium-channel blockers	0.256	0.744	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.256	0.744	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.245	0.754	0.000
T45.8 Other primarily systemic and haematological agents	0.245	0.754	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.245	0.754	0.000
T45.6 Fibrinolysis-affecting drugs	0.245	0.754	0.000
T45.4 Iron and its compounds	0.245	0.754	0.000
T45.3 Enzymes, not elsewhere classified	0.245	0.754	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.245	0.755	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.244	0.756	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.243	0.756	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.243	0.757	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.243	0.757	0.000
T46.7 Peripheral vasodilators	0.243	0.757	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.243	0.757	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.243	0.757	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.243	0.757	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.239	0.760	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.239	0.760	0.000
T42.3 Barbiturates	0.239	0.760	0.000
T42.2 Succinimides and oxazolidinediones	0.239	0.760	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.237	0.763	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.235	0.764	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.233	0.767	0.000
T36 Poisoning by systemic antibiotics	0.228	0.772	0.000
T40.2 Other opioids	0.228	0.772	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.218	0.781	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.218	0.781	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.218	0.781	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.218	0.781	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.218	0.781	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.218	0.781	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.218	0.781	0.000
T44.0 Anticholinesterase agents	0.218	0.781	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.217	0.783	0.000
T40.4 Other synthetic narcotics	0.215	0.785	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.202	0.798	0.000
T37.5 Antiviral drugs	0.202	0.798	0.000
T37.4 Anthelminthics	0.202	0.798	0.000
T37.3 Other antiprotozoal drugs	0.202	0.798	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.202	0.798	0.000
T37.1 Antimycobacterial drugs	0.202	0.798	0.000
T37.0 Sulphonamides	0.202	0.798	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.199	0.800	0.000
T40.8 Lysergide [LSD]	0.199	0.800	0.000
T40.7 Cannabis (derivatives)	0.199	0.800	0.000
T40.5 Cocaine	0.199	0.800	0.000
T40.3 Methadone	0.199	0.800	0.000
T40.1 Heroin	0.199	0.800	0.000
T40.0 Opium	0.199	0.800	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.197	0.803	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.193	0.807	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.193	0.807	0.000
T47.7 Emetics	0.193	0.807	0.000
T47.6 Antidiarrhoeal drugs	0.193	0.807	0.000
T47.5 Digestants	0.193	0.807	0.000
T47.4 Other laxatives	0.193	0.807	0.000
T47.3 Saline and osmotic laxatives	0.193	0.807	0.000
T47.2 Stimulant laxatives	0.193	0.807	0.000
T47.0 Histamine H(2)-receptor antagonists	0.193	0.807	0.000
T41.5 Therapeutic gases	0.191	0.809	0.000
T41.4 Anaesthetic, unspecified	0.191	0.809	0.000
T41.3 Local anaesthetics	0.191	0.809	0.000
T41.2 Other and unspecified general anaesthetics	0.191	0.809	0.000
T41.1 Intravenous anaesthetics	0.191	0.809	0.000
T41.0 Inhaled anaesthetics	0.191	0.809	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.191	0.809	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.191	0.809	0.000
T48.5 Anti-common-cold drugs	0.191	0.809	0.000
T48.4 Expectorants	0.191	0.809	0.000
T48.3 Antitussives	0.191	0.809	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.191	0.809	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.191	0.809	0.000
T48.0 Oxytocic drugs	0.191	0.809	0.000
T49.9 Topical agent, unspecified	0.191	0.809	0.000
T49.8 Other topical agents	0.191	0.809	0.000
T49.7 Dental drugs, topically applied	0.191	0.809	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.191	0.809	0.000
T49.5 Ophthalmological drugs and preparations	0.191	0.809	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.191	0.809	0.000
T49.3 Emollients, demulcents and protectants	0.191	0.809	0.000
T49.2 Local astringents and local detergents	0.191	0.809	0.000
T49.1 Antipruritics	0.191	0.809	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.191	0.809	0.000
T38.1 Thyroid hormones and substitutes	0.169	0.830	0.000
T38.9 Other and unspecified hormone antagonists	0.167	0.833	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.167	0.833	0.000
T38.7 Androgens and anabolic congeners	0.167	0.833	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.167	0.833	0.000
T38.5 Other oestrogens and progestogens	0.167	0.833	0.000
T38.4 Oral contraceptives	0.167	0.833	0.000
T38.2 Antithyroid drugs	0.167	0.833	0.000
T38.0 Glucocorticoids and synthetic analogues	0.167	0.833	0.000
T36.9 Systemic antibiotic, unspecified	0.164	0.836	0.000
T36.8 Other systemic antibiotics	0.164	0.836	0.000
T36.7 Antifungal antibiotics, systemically used	0.164	0.836	0.000
T36.6 Rifamycins	0.164	0.836	0.000
T36.5 Aminoglycosides	0.164	0.836	0.000
T36.4 Tetracyclines	0.164	0.836	0.000
T36.3 Macrolides	0.164	0.836	0.000
T36.2 Chloramphenicol group	0.164	0.836	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.164	0.836	0.000
T42.4 Benzodiazepines	0.150	0.850	0.000
T40.6 Other and unspecified narcotics	0.148	0.852	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.130	0.869	0.000
T36.0 Penicillins	0.126	0.874	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.087	0.913	0.000
T43.9 Psychotropic drug, unspecified	0.063	0.937	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.063	0.937	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.063	0.937	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.062	0.938	0.000
T43.2 Other and unspecified antidepressants	0.055	0.945	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.055	0.945	0.000
T43.6 Psychostimulants with abuse potential	0.054	0.946	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.043	0.957	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.038	0.962	0.000
C56 Malignant neoplasm of ovary	0.000	0.983	0.017
S62.60 Fracture of other finger (closed)	0.017	0.983	0.000
H61.0 Perichondritis of external ear	0.013	0.987	0.000
R03.1 Nonspecific low blood-pressure reading	0.010	0.990	0.000
Z12.1 Special screening examination for neoplasm of intestinal tract	0.000	0.990	0.010
E89.0 Postprocedural hypothyroidism	0.000	0.991	0.009
R42 Dizziness and giddiness	0.000	0.992	0.008
H54.9 Unspecified visual impairment (binocular)	0.007	0.993	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.000	0.993	0.007
E89.2 Postprocedural hypoparathyroidism	0.000	0.993	0.007
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.007	0.993	0.000
N60.2 Fibroadenosis of breast	0.000	0.994	0.006
M46.9 Inflammatory spondylopathy, unspecified	0.006	0.994	0.000
S62.6 Fracture of other finger	0.006	0.994	0.000
H54 Blindness and low vision	0.006	0.994	0.000
N60 Benign mammary dysplasia	0.000	0.994	0.006
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.006	0.994	0.000
H54.4 Blindness, one eye	0.006	0.994	0.000
E89.3 Postprocedural hypopituitarism	0.000	0.994	0.006
N60.9 Benign mammary dysplasia, unspecified	0.000	0.994	0.006
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.006	0.994	0.000
N60.0 Solitary cyst of breast	0.000	0.994	0.006
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.006	0.994	0.000
N60.3 Fibrosclerosis of breast	0.000	0.994	0.005
C51-C58 Malignant neoplasms of female genital organs	0.000	0.994	0.005
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.000	0.995	0.005
H54.7 Unspecified visual loss	0.005	0.995	0.000
N60.4 Mammary duct ectasia	0.000	0.995	0.005
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.000	0.995	0.005
E89.8 Other postprocedural endocrine and metabolic disorders	0.000	0.995	0.005
E89.5 Postprocedural testicular hypofunction	0.000	0.995	0.005
E89.4 Postprocedural ovarian failure	0.000	0.995	0.005
E89.1 Postprocedural hypoinsulinaemia	0.000	0.995	0.005
R44 Other symptoms and signs involving general sensations and perceptions	0.000	0.995	0.005
H54.2 Low vision, both eyes	0.005	0.995	0.000
K14.8 Other diseases of tongue	0.000	0.995	0.005
H54.6 Unqualified visual loss, one eye	0.005	0.995	0.000
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.005	0.995	0.000
H54.0 Blindness, both eyes	0.005	0.995	0.000
R44.0 Auditory hallucinations	0.000	0.995	0.005
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.005	0.995	0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.005	0.995	0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.005	0.995	0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.005	0.995	0.000
H54.1 Blindness, one eye, low vision, other eye	0.005	0.995	0.000
C51 Malignant neoplasm of vulva	0.000	0.995	0.005
H54.3 Unqualified visual loss, both eyes	0.005	0.995	0.000
C55 Malignant neoplasm of uterus, part unspecified	0.000	0.995	0.005
R44.3 Hallucinations, unspecified	0.000	0.995	0.005
A41.5 Septicaemia due to other Gram-negative organisms	0.000	0.995	0.005
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.000	0.995	0.004
R44.1 Visual hallucinations	0.000	0.996	0.004
C58 Malignant neoplasm of placenta	0.000	0.996	0.004
Z98.0 Intestinal bypass and anastomosis status	0.000	0.996	0.004
R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions	0.000	0.996	0.004
C51.9 Vulva, unspecified	0.000	0.996	0.004
H54.5 Low vision, one eye	0.004	0.996	0.000
R40.2 Coma, unspecified	0.000	0.996	0.004
R40-R46 Symptoms and signs involving cognition, perception, emotional state and behaviour	0.000	0.996	0.004
C57 Malignant neoplasm of other and unspecified female genital organs	0.000	0.996	0.004
C52 Malignant neoplasm of vagina	0.000	0.996	0.004
H04.2 Epiphora	0.004	0.996	0.000
N60.8 Other benign mammary dysplasias	0.000	0.996	0.004
S62.61 Fracture of other finger (open)	0.004	0.996	0.000
N60.1 Diffuse cystic mastopathy	0.000	0.996	0.004
R44.2 Other hallucinations	0.000	0.996	0.004
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.004	0.996	0.000
M46 Other inflammatory spondylopathies	0.004	0.996	0.000
R40 Somnolence, stupor and coma	0.000	0.996	0.004
M21.67 Other acquired deformities of ankle and foot-Ankle/foot	0.000	0.996	0.004
C51.8 Overlapping lesion of vulva	0.000	0.996	0.003
C51.2 Clitoris	0.000	0.996	0.003
C51.1 Labium minus	0.000	0.996	0.003
C51.0 Labium majus	0.000	0.996	0.003
E61.1 Iron deficiency	0.000	0.996	0.004
C53 Malignant neoplasm of cervix uteri	0.000	0.996	0.003
J44.9 Chronic obstructive pulmonary disease, unspecified	0.004	0.996	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.003	0.997	0.000
C53.0 Endocervix	0.000	0.997	0.003
C57.9 Female genital organ, unspecified	0.000	0.997	0.003
C57.8 Overlapping lesion of female genital organs	0.000	0.997	0.003
C57.7 Other specified female genital organs	0.000	0.997	0.003
C57.4 Uterine adnexa, unspecified	0.000	0.997	0.003
C57.3 Parametrium	0.000	0.997	0.003
C57.2 Round ligament	0.000	0.997	0.003
C57.1 Broad ligament	0.000	0.997	0.003
X63.0 Home	0.003	0.997	0.000
H61 Other disorders of external ear	0.003	0.997	0.000
M46.4 Discitis, unspecified	0.003	0.997	0.000
M46.1 Sacro-iliitis, not elsewhere classified	0.003	0.997	0.000
M46.3 Infection of intervertebral disk (pyogenic)	0.003	0.997	0.000
C57.0 Fallopian tube	0.000	0.997	0.003
R43 Disturbances of smell and taste	0.000	0.997	0.003
H61.8 Other specified disorders of external ear	0.003	0.997	0.000
M46.8 Other specified inflammatory spondylopathies	0.003	0.997	0.000
M46.5 Other infective spondylopathies	0.003	0.997	0.000
M46.2 Osteomyelitis of vertebra	0.003	0.997	0.000
M46.0 Spinal enthesopathy	0.003	0.997	0.000
C53.8 Overlapping lesion of cervix uteri	0.000	0.997	0.003
C53.1 Exocervix	0.000	0.997	0.003
M46.42 Discitis, unspecified (Cervical region)	0.003	0.997	0.000
R45 Symptoms and signs involving emotional state	0.000	0.997	0.003
C54 Malignant neoplasm of corpus uteri	0.000	0.997	0.003
M46.18 Sacroiliitis, not elsewhere classified-Sacral/sacrococ	0.003	0.997	0.000
M46.47 Discitis, unspecified (Lumbosacral region)	0.003	0.997	0.000
R45.1 Restlessness and agitation	0.000	0.997	0.003
R40.0 Somnolence	0.000	0.997	0.003
D03.7 Melanoma in situ of lower limb, including hip	0.003	0.997	0.000
M46.36 Infection of intervertebral disc (pyogenic) (Lumbar region)	0.002	0.997	0.000
M46.44 Discitis, unspecified (Thoracic region)	0.002	0.997	0.000
J44 Other chronic obstructive pulmonary disease	0.003	0.997	0.000
M46.19 Sacroiliitis, not elsewhere classified-Site unspe	0.002	0.997	0.000
M46.17 Sacroiliitis, not elsewhere classified-Lumbosacral	0.002	0.997	0.000
M46.16 Sacroiliitis, not elsewhere classified-Lumbar	0.002	0.997	0.000
M46.15 Sacroiliitis, not elsewhere classified-Thoracolumbar	0.002	0.997	0.000
M46.14 Sacroiliitis, not elsewhere classified-Thoracic	0.002	0.997	0.000
M46.13 Sacroiliitis, not elsewhere classified-Cervicothoracic	0.002	0.997	0.000
M46.12 Sacroiliitis, not elsewhere classified-Cervical	0.002	0.997	0.000
M46.11 Sacroiliitis, not elsewhere classified-Occipit-atl-axl	0.002	0.997	0.000
M46.10 Sacroiliitis, not elsewhere classified-Mult site	0.002	0.997	0.000
M46.49 Discitis, unspecified (Site unspecified)	0.002	0.997	0.000
M46.48 Discitis, unspecified (Sacral and sacrococcygeal region)	0.002	0.997	0.000
M46.45 Discitis, unspecified (Thoracolumbar region)	0.002	0.997	0.000
M46.43 Discitis, unspecified (Cervicothoracic region)	0.002	0.997	0.000
M46.41 Discitis, unspecified (Occipito-atlanto-axial region)	0.002	0.997	0.000
M46.40 Discitis, unspecified (Multiple sites in spine)	0.002	0.997	0.000
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.000	0.997	0.002
M46.39 Infection of intervertebral disc (pyogenic) (Site unspecified)	0.002	0.998	0.000
M46.38 Infection of intervertebral disc (pyogenic) (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.37 Infection of intervertebral disc (pyogenic) (Lumbosacral region)	0.002	0.998	0.000
M46.35 Infection of intervertebral disc (pyogenic) (Thoracolumbar region)	0.002	0.998	0.000
M46.34 Infection of intervertebral disc (pyogenic) (Thoracic region)	0.002	0.998	0.000
M46.33 Infection of intervertebral disc (pyogenic) (Cervicothoracic region)	0.002	0.998	0.000
M46.32 Infection of intervertebral disc (pyogenic) (Cervical region)	0.002	0.998	0.000
M46.31 Infection of intervertebral disc (pyogenic) (Occipito-atlanto-axial region)	0.002	0.998	0.000
M46.30 Infection of intervertebral disc (pyogenic) (Multiple sites in spine)	0.002	0.998	0.000
M10.97 Gout, unspecified (Ankle and foot)	0.000	0.998	0.002
H61.9 Disorder of external ear, unspecified	0.002	0.998	0.000
R43.2 Parageusia	0.000	0.998	0.002
R43.1 Parosmia	0.000	0.998	0.002
C43.7 Malignant melanoma of lower limb, including hip	0.000	0.998	0.002
M46.09 Spinal enthesopathy (Site unspecified)	0.002	0.998	0.000
M46.08 Spinal enthesopathy (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.07 Spinal enthesopathy (Lumbosacral region)	0.002	0.998	0.000
M46.06 Spinal enthesopathy (Lumbar region)	0.002	0.998	0.000
M46.05 Spinal enthesopathy (Thoracolumbar region)	0.002	0.998	0.000
M46.04 Spinal enthesopathy (Thoracic region)	0.002	0.998	0.000
M46.03 Spinal enthesopathy (Cervicothoracic region)	0.002	0.998	0.000
M46.02 Spinal enthesopathy (Cervical region)	0.002	0.998	0.000
M46.01 Spinal enthesopathy (Occipito-atlanto-axial region)	0.002	0.998	0.000
M46.00 Spinal enthesopathy (Multiple sites in spine)	0.002	0.998	0.000
M46.29 Osteomyelitis of vertebra (Site unspecified)	0.002	0.998	0.000
M46.28 Osteomyelitis of vertebra (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.27 Osteomyelitis of vertebra (Lumbosacral region)	0.002	0.998	0.000
M46.26 Osteomyelitis of vertebra (Lumbar region)	0.002	0.998	0.000
M46.25 Osteomyelitis of vertebra (Thoracolumbar region)	0.002	0.998	0.000
M46.24 Osteomyelitis of vertebra (Thoracic region)	0.002	0.998	0.000
M46.23 Osteomyelitis of vertebra (Cervicothoracic region)	0.002	0.998	0.000
M46.22 Osteomyelitis of vertebra (Cervical region)	0.002	0.998	0.000
M46.21 Osteomyelitis of vertebra (Occipito-atlanto-axial region)	0.002	0.998	0.000
M46.20 Osteomyelitis of vertebra (Multiple sites in spine)	0.002	0.998	0.000
M46.59 Other infective spondylopathies (Site unspecified)	0.002	0.998	0.000
M46.58 Other infective spondylopathies (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.57 Other infective spondylopathies (Lumbosacral region)	0.002	0.998	0.000
M46.56 Other infective spondylopathies (Lumbar region)	0.002	0.998	0.000
M46.55 Other infective spondylopathies (Thoracolumbar region)	0.002	0.998	0.000
M46.54 Other infective spondylopathies (Thoracic region)	0.002	0.998	0.000
M46.53 Other infective spondylopathies (Cervicothoracic region)	0.002	0.998	0.000
M46.52 Other infective spondylopathies (Cervical region)	0.002	0.998	0.000
M46.51 Other infective spondylopathies (Occipito-atlanto-axial region)	0.002	0.998	0.000
M46.50 Other infective spondylopathies (Multiple sites in spine)	0.002	0.998	0.000
M46.89 Other specified inflammatory spondylopathies (Site unspecified)	0.002	0.998	0.000
M46.88 Other specified inflammatory spondylopathies (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M46.87 Other specified inflammatory spondylopathies (Lumbosacral region)	0.002	0.998	0.000
M46.86 Other specified inflammatory spondylopathies (Lumbar region)	0.002	0.998	0.000
M46.85 Other specified inflammatory spondylopathies (Thoracolumbar region)	0.002	0.998	0.000
M46.84 Other specified inflammatory spondylopathies (Thoracic region)	0.002	0.998	0.000
M46.83 Other specified inflammatory spondylopathies (Cervicothoracic region)	0.002	0.998	0.000
M46.82 Other specified inflammatory spondylopathies (Cervical region)	0.002	0.998	0.000
M46.81 Other specified inflammatory spondylopathies (Occipito-atlanto-axial region)	0.002	0.998	0.000
M46.80 Other specified inflammatory spondylopathies (Multiple sites in spine)	0.002	0.998	0.000
R43.0 Anosmia	0.000	0.998	0.002
R46 Symptoms and signs involving appearance and behaviour	0.000	0.998	0.002
I35.1 Aortic (valve) insufficiency	0.000	0.998	0.002
C54.9 Corpus uteri, unspecified	0.000	0.998	0.002
K60.1 Chronic anal fissure	0.002	0.998	0.000
D13.1 Stomach	0.002	0.998	0.000
R40.1 Stupor	0.000	0.998	0.002
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified	0.000	0.998	0.002
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
R43.8 Other and unspecified disturbances of smell and taste	0.000	0.998	0.002
C54.8 Overlapping lesion of corpus uteri	0.000	0.998	0.002
C54.3 Fundus uteri	0.000	0.998	0.002
C54.2 Myometrium	0.000	0.998	0.002
C54.0 Isthmus uteri	0.000	0.998	0.002
K60.5 Anorectal fistula	0.002	0.998	0.000
R45.6 Physical violence	0.000	0.998	0.002
R45.5 Hostility	0.000	0.998	0.002
R45.3 Demoralisation and apathy	0.000	0.998	0.002
Z45.0 Adjustment and management of cardiac pacemaker	0.002	0.998	0.000
S82.40 Fracture of fibula alone (closed)	0.000	0.998	0.002
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.002	0.998	0.000
Q50.4 Embryonic cyst of Fallopian tube	0.002	0.998	0.000
K60.0 Acute anal fissure	0.002	0.998	0.000
M21.6 Other acquired deformities of ankle and foot	0.000	0.998	0.002
R46.4 Slowness and poor responsiveness	0.000	0.998	0.002
J32.4 Chronic pansinusitis	0.000	0.998	0.002
R45.7 State of emotional shock and stress, unspecified	0.000	0.998	0.002
H61.1 Non-infective disorders of pinna	0.002	0.998	0.000
R45.8 Other symptoms and signs involving emotional state	0.000	0.998	0.002
H61.3 Acquired stenosis of external ear canal	0.002	0.998	0.000
G40.8 Other epilepsy	0.000	0.998	0.002
M46.46 Discitis, unspecified (Lumbar region)	0.002	0.998	0.000
R45.0 Nervousness	0.000	0.998	0.002
E61 Deficiency of other nutrient elements	0.000	0.998	0.002
R45.4 Irritability and anger	0.000	0.998	0.002
I27.2 Other secondary pulmonary hypertension	0.000	0.998	0.002
R46.7 Verbosity and circumstantial detail obscuring reason for contact	0.000	0.998	0.002
R46.6 Undue concern and preoccupation with stressful events	0.000	0.998	0.002
R46.5 Suspiciousness and marked evasiveness	0.000	0.998	0.002
R46.3 Overactivity	0.000	0.998	0.002
R46.1 Bizarre personal appearance	0.000	0.998	0.002
B02.9 Zoster without complication	0.000	0.998	0.002
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.000	0.998	0.002
K60 Fissure and fistula of anal and rectal regions	0.002	0.998	0.000
S92.41 Fracture of great toe (open)	0.002	0.998	0.000
Q61.2 Polycystic kidney, adult type	0.002	0.998	0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.000	0.998	0.002
X63.9 Unspecified place	0.002	0.998	0.000
X63.8 Other specified place	0.002	0.998	0.000
X63.7 Farm	0.002	0.998	0.000
X63.6 Industrial and construction area	0.002	0.998	0.000
X63.5 Trade and service area	0.002	0.998	0.000
X63.4 Street and highway	0.002	0.998	0.000
X63.3 Sports and athletics area	0.002	0.998	0.000
X63.2 School, other institution and public administrative area	0.002	0.998	0.000
X63.1 Residential institution	0.002	0.998	0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.000	0.998	0.002
N81.9 Female genital prolapse, unspecified	0.002	0.998	0.000
M21.69 Other acquired deformities of ankle and foot-Site unspec	0.000	0.998	0.002
M21.68 Other acquired deformities of ankle and foot-Other	0.000	0.998	0.002
M21.66 Other acquired deformities of ankle and foot-Lower leg	0.000	0.998	0.002
M21.65 Other acquired deformities of ankle and foot-Pelvic/thigh	0.000	0.998	0.002
M21.64 Other acquired deformities of ankle and foot-Hand	0.000	0.998	0.002
M21.63 Other acquired deformities of ankle and foot-Forearm	0.000	0.998	0.002
M21.62 Other acquired deformities of ankle and foot-Upper arm	0.000	0.998	0.002
M21.61 Other acquired deformities of ankle and foot-Shldr region	0.000	0.998	0.002
M21.60 Other acquired deformities of ankle and foot-Mult sites	0.000	0.998	0.002
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.000	0.998	0.002
S13.4 Sprain and strain of cervical spine	0.002	0.998	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.000	0.998	0.002
G40 Epilepsy	0.000	0.998	0.002
R03 Abnormal blood-pressure reading, without diagnosis	0.002	0.998	0.000
E53.8 Deficiency of other specified B group vitamins	0.000	0.998	0.002
R45.2 Unhappiness	0.000	0.998	0.002
S92.30 Fracture of metatarsal bone (closed)	0.002	0.998	0.000
I72.4 Aneurysm of artery of lower extremity	0.000	0.998	0.002
S92.4 Fracture of great toe	0.002	0.998	0.000
E61.9 Deficiency of nutrient element, unspecified	0.000	0.998	0.002
E61.8 Deficiency of other specified nutrient elements	0.000	0.998	0.002
E61.7 Deficiency of multiple nutrient elements	0.000	0.998	0.002
E61.6 Vanadium deficiency	0.000	0.998	0.002
E61.5 Molybdenum deficiency	0.000	0.998	0.002
E61.4 Chromium deficiency	0.000	0.998	0.002
E61.3 Manganese deficiency	0.000	0.998	0.002
E61.0 Copper deficiency	0.000	0.998	0.002
R46.0 Very low level of personal hygiene	0.001	0.998	0.001
I27.8 Other specified pulmonary heart diseases	0.000	0.998	0.002
L60.0 Ingrowing nail	0.000	0.998	0.002
Q66.8 Other congenital deformities of feet	0.002	0.998	0.000
H83.0 Labyrinthitis	0.002	0.998	0.000
R46.2 Strange and inexplicable behaviour	0.000	0.998	0.001
S92.3 Fracture of metatarsal bone	0.002	0.998	0.000
G40.5 Special epileptic syndromes	0.000	0.998	0.002
D22.7 Melanocytic naevi of lower limb, including hip	0.000	0.998	0.002
E61.2 Magnesium deficiency	0.000	0.998	0.001
X63.99 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system; Unspecified place ;During unspecified activity	0.001	0.998	0.000
S92.00 Fracture of calcaneus (closed)	0.002	0.998	0.000
I27.0 Primary pulmonary hypertension	0.000	0.998	0.002
S92.0 Fracture of calcaneus	0.002	0.998	0.000
S92 Fracture of foot, except ankle	0.002	0.998	0.000
M77.12 Lateral epicondylitis (Upper arm)	0.000	0.998	0.002
J32.0 Chronic maxillary sinusitis	0.000	0.998	0.002
G40.4 Other generalised epilepsy and epileptic syndromes	0.000	0.998	0.001
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.000	0.998	0.001
R46.8 Other symptoms and signs involving appearance and behaviour	0.000	0.998	0.001
S83.2 Tear of meniscus, current	0.000	0.998	0.002
I27 Other pulmonary heart diseases	0.000	0.998	0.002
K60.3 Anal fistula	0.002	0.998	0.000
K60.2 Anal fissure, unspecified	0.002	0.998	0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.001	0.998	0.000
S92.40 Fracture of great toe (closed)	0.001	0.998	0.000
R19.5 Other fecal abnormalities	0.000	0.998	0.002
X60.1 Residential institution	0.001	0.998	0.000
X60-X84 Intentional self-harm	0.002	0.998	0.000
M87.20 Osteonecrosis due to previous trauma (Multiple sites)	0.001	0.998	0.000
F84.5 Asperger's syndrome	0.001	0.998	0.000
S92.5 Fracture of other toe	0.001	0.998	0.000
S92.2 Fracture of other tarsal bone(s)	0.001	0.998	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.001	0.998	0.000
S92.51 Fracture of other toe (open)	0.001	0.998	0.000
C53.9 Cervix uteri, unspecified	0.000	0.998	0.001
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.000	0.998	0.001
R49.0 Dysphonia	0.002	0.998	0.000
Z60.2 Living alone	0.002	0.998	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.001	0.998	0.000
S92.31 Fracture of metatarsal bone (open)	0.001	0.999	0.000
X68.9 Unspecified place	0.001	0.999	0.000
X69.0 Home	0.001	0.999	0.000
H04 Disorders of lachrymal system	0.001	0.999	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.001	0.999	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.001	0.999	0.000
M24.47 Recurrent dislocation and subluxation of joint (Ankle and foot)	0.001	0.999	0.000
Q61.5 Medullary cystic kidney	0.001	0.999	0.000
Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung	0.000	0.999	0.001
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.001	0.999	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.001	0.999	0.000
S92.01 Fracture of calcaneus (open)	0.001	0.999	0.000
F84.0 Childhood autism	0.001	0.999	0.000
G55.3 Nerve root and plexus compressions in other dorsopathies	0.000	0.999	0.001
H04.4 Chronic inflammation of lachrymal passages	0.001	0.999	0.000
H35.8 Other specified retinal disorders	0.001	0.999	0.000
S92.9 Fracture of foot, unspecified	0.001	0.999	0.000
X65.8 Other specified place	0.001	0.999	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.001	0.999	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.001	0.999	0.000
Q61.3 Polycystic kidney, unspecified	0.001	0.999	0.000
H04.8 Other disorders of lachrymal system	0.001	0.999	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.001	0.999	0.000
Q61 Cystic kidney disease	0.001	0.999	0.000
M21.26 Flexion deformity (Lower leg)	0.000	0.999	0.001
M24.15 Other articular cartilage disorders (Pelvic region and thigh)	0.001	0.999	0.000
I27.1 Kyphoscoliotic heart disease	0.000	0.999	0.001
K60.4 Rectal fistula	0.001	0.999	0.000
S92.7 Multiple fractures of foot	0.001	0.999	0.000
M24.96 Joint derangement, unspecified (Lower leg)	0.001	0.999	0.000
X69.9 Unspecified place	0.001	0.999	0.000
X84 Intentional self-harm by unspecified means	0.001	0.999	0.000
X83 Intentional self-harm by other specified means	0.001	0.999	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.001	0.999	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.001	0.999	0.000
X80 Intentional self-harm by jumping from a high place	0.001	0.999	0.000
X79 Intentional self-harm by blunt object	0.001	0.999	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.001	0.999	0.000
X76 Intentional self-harm by smoke, fire and flames	0.001	0.999	0.000
X75 Intentional self-harm by explosive material	0.001	0.999	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations